Tumor factors, but not cirrhosis, drive the development of baseline and incident ascites in surgically resected cholangiocarcinoma: a retrospective cohort study
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Portal hypertension-related complications have emerged as important prognostic determinants in patients with cholangiocarcinoma (CCA), yet the clinical impact and pathophysiological drivers of ascites in this population have never been systematically investigated. This study aimed to clarify the impact of ascites on overall survival (OS) in patients with surgically resected CCA using a time-dependent approach and to identify the risk factors underlying baseline and incident ascites. Methods We retrospectively reviewed patients with CCA who underwent surgical resection at Taipei Veterans General Hospital between January 2013 and December 2023. Of 842 patients screened, 195 with an available histological ISHAK fibrosis assessment formed the cirrhosis-assessed cohort (baseline ascites, n = 55; no baseline ascites, n = 140). Ascites was modeled as a time-dependent covariate in a Cox analysis of OS to avoid immortal-time bias; risk factors for baseline ascites (logistic regression) and incident ascites (cause-specific Cox regression) were examined, with multiple imputation for missing data. Results Patients with baseline ascites had more late-stage tumors (III–IV, 40.0% vs. 21.6%, p = 0.009), higher CA19-9 (p = 0.001), and worse ALBI scores (p = 0.045), whereas the prevalence of cirrhosis (ISHAK > 4) did not differ (27.3% vs. 22.9%, p = 0.517). Baseline ascites was associated with worse OS (median 876 vs. 2026 days, log-rank p = 0.037). In the adjusted time-dependent model, baseline ascites (HR 1.94, 95% CI 1.12–3.38, p = 0.018) and incident ascites (HR 3.24, 95% CI 1.81–5.80, p < 0.001) independently predicted OS; ALBI grade 2/3 (HR 2.14, p = 0.002) and CA19-9 > 38 U/mL (HR 2.03, p = 0.003) were also independent predictors. Baseline ascites was independently driven by tumor factors (CA19-9 > 38 U/mL: OR 2.22, p = 0.027; clinical stage per stage: OR 1.40, p = 0.049), whereas incident ascites was driven by clinical stage (HR 1.60, p = 0.007) and macrovascular invasion (HR 4.56, p = 0.002). Conclusions In surgically resected CCA patients, baseline and incident ascites were driven predominantly by tumor factors—not by the structural status of cirrhosis—and both, particularly incident ascites, were in turn independently associated with poorer survival. Tumor factors, but not cirrhosis, determined the development of ascites in this population.
Source: Research Square
Institution: Taipei Veterans General Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225861744
